Top

Published in:

01-07-2016 | Case Report

Efficacy of Endeavor zotarolimus-eluting stent implantation for the treatment of very late stent thrombosis with late-acquired incomplete stent apposition after sirolimus-eluting stent implantation

Authors: Yuki Kakefuda, Akira Sato, Hiroaki Watabe, Hideaki Aihara, Hidetaka Nishina, Yuichi Noguchi, Tomoya Hoshi, Kazutaka Aonuma

Published in: Heart and Vessels | Issue 7/2016

Abstract

Very late stent thrombosis (VLST) is a serious complication after percutaneous coronary intervention. However, the best therapy for VLST with late-acquired incomplete stent apposition and incomplete neointimal coverage remains unknown. In these cases, neointimal coverage was nearly complete and no late-acquired malapposition was detected at 18 months after Endeavor zotarolimus-eluting stent (ZES) implantation for the treatment of VLST with late-acquired incomplete stent apposition after sirolimus-eluting stent implantation. We presented that Endeavor ZES implantation may become an attractive therapeutic strategy for the treatment of VLST with late-acquired incomplete stent apposition and incomplete neointimal coverage.

Available only for authorised users

Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, Colombo A, Schampaert E, Grube E, Kirtane AJ, Cutlip DE, Fahy M, Pocock SJ, Mehran R, Leon MB (2007) Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 356:998–1008CrossRefPubMed

Yamawaki M, Onuma Y, Nakano M, Muramatsu T, Nakatani S, Ishibashi Y, Ishimori H, Hirano K, Ito Y, Tsukahara R, Muramatsu T (2014) Simultaneous occlusion of left anterior descending and left circumflex arteries by very late stent thrombosis: vascular response to drug-eluting stents assessed by intravascular ultrasound. Heart Vessels. doi:10.1007/s00380-014-0545-0

Mahmoud KD, Vlaar PJ, van den Heuvel AF, Hillege HL, Zijlstra F, de Smet BJ (2011) Usefulness of thrombus aspiration for the treatment of coronary stent thrombosis. Am J Cardiol 108:1721–1727CrossRefPubMed

Nasuno T, Tokura M, Kageyama M, Toyoda S, Sakuma M, Komatsu T, Taguchi I, Abe S, Inoue T (2015) The wound healing response after implantation of a drug-eluting stent is impaired persistently in the long term. Heart Vessels. doi:10.1007/s00380-015-0676-y PubMedCentral

Fajadet J, Wijns W, Laarman GJ, Kuck KH, Ormiston J, Münzel T, Popma JJ, Fitzgerald PJ, Bonan R, Kuntz RE, Investigators ENDEAVORII (2006) Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial. Circulation 114:798–806CrossRefPubMed

Kim JS, Jang IK, Fan C, Kim TH, Kim JS, Park SM, Choi EY, Lee SH, Ko YG, Choi D, Hong MK, Jang Y (2009) Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implamtation by optical coherence tomography: the ENDEAVOR OCT trial. JACC Cardiovasc Interv 2:1240–1247CrossRefPubMed

Basalus MW, Ankone MJ, van Houwelingen GK, de Man FH, von Birgelen C (2009) Coating irregularities of durable polymer-based drug-eluting stents as assessed by scanning electron microscopy. Euro Interv 5:157–165

von Birgelen C, Basalus MW (2010) On the loss of the phosphorylcholine-based DES coating on the abluminal surface of Endeavor stents. Catheter Cardiovasc Interv 76:158–159CrossRef

Title: Efficacy of Endeavor zotarolimus-eluting stent implantation for the treatment of very late stent thrombosis with late-acquired incomplete stent apposition after sirolimus-eluting stent implantation
Authors: Yuki Kakefuda
Akira Sato
Hiroaki Watabe
Hideaki Aihara
Hidetaka Nishina
Yuichi Noguchi
Tomoya Hoshi
Kazutaka Aonuma
Publication date: 01-07-2016
Publisher: Springer Japan
Published in: Heart and Vessels / Issue 7/2016
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI: https://doi.org/10.1007/s00380-015-0720-y

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Efficacy of Endeavor zotarolimus-eluting stent implantation for the treatment of very late stent thrombosis with late-acquired incomplete stent apposition after sirolimus-eluting stent implantation

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 7/2016

Heterogenous haemodynamic effects of adaptive servoventilation therapy in sleeping patients with heart failure and Cheyne–Stokes respiration compared to healthy volunteers

Axillary artery cannulation provides balanced cerebral oxygenation

Increased p-cresyl sulfate level is independently associated with poor outcomes in patients with heart failure

Progression from stenosis to occlusion in the proximal native coronary artery after coronary artery bypass grafting

Association between smoking habits and severity of coronary stenosis as assessed by coronary computed tomography angiography

Short- and long-term inhibition of cardiac inward-rectifier potassium channel current by an antiarrhythmic drug bepridil

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page